levofloxacin has been researched along with entinostat in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (entinostat) | Trials (entinostat) | Recent Studies (post-2010) (entinostat) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 557 | 31 | 402 |
| Protein | Taxonomy | levofloxacin (IC50) | entinostat (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 1.5547 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.73 | |
| Tissue factor | Homo sapiens (human) | 8 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 3.93 | |
| Histone deacetylase 4 | Homo sapiens (human) | 2.5077 | |
| Histone deacetylase 1 | Homo sapiens (human) | 1.0631 | |
| Histone deacetylase 7 | Homo sapiens (human) | 2.7679 | |
| Histone deacetylase 2 | Homo sapiens (human) | 1.4517 | |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | 3.1451 | |
| Histone deacetylase 11 | Homo sapiens (human) | 3.3762 | |
| Histone deacetylase 8 | Homo sapiens (human) | 3.5118 | |
| Histone deacetylase 6 | Homo sapiens (human) | 2.9645 | |
| Histone deacetylase 9 | Homo sapiens (human) | 2.9949 | |
| Histone deacetylase 5 | Homo sapiens (human) | 2.7109 | |
| Histone deacetylase | Plasmodium falciparum (malaria parasite P. falciparum) | 0.94 | |
| Nuclear receptor corepressor 2 | Homo sapiens (human) | 1.185 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abuo-Rahma, GEA; Badr, M; Bass, AKA; El-Zoghbi, MS; Mohamed, MFA; Nageeb, EM | 1 |
1 review(s) available for levofloxacin and entinostat
| Article | Year |
|---|---|
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.
Topics: Androgen Antagonists; Animals; Antineoplastic Agents; Benzimidazoles; Cyclic Nucleotide Phosphodiesterases, Type 5; Daunorubicin; Doxorubicin; fms-Like Tyrosine Kinase 3; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Molecular Targeted Therapy; Morpholines; Nicotinamide Phosphoribosyltransferase; Nitric Oxide; Pyrimidines; Quinazolines; Structure-Activity Relationship; Transcription Factors | 2021 |